EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19

Evelyn Kung, Rinki Deo, Manish C Choudhary, Kara W Chew, Teresa H Evering, Rachel Bender Ignacio, Prasanna Jagannathan, James P Flynn, James Regan, Carlee Moser, Mark J Giganti, Michael D Hughes und 13 weitere

Pathogens and Immunity · 06.05.2026 · 11 (1) · 142-153

DOI: 10.20411/pai.v11i1.971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens and Immunity, online erschienen am 06.05.2026. Verfasst von Evelyn Kung und 24 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate the impact of sex on acute SARS-CoV-2 infection, 668 participants from the ACTIV-2/A5401 study were followed over a 28-day period.

Methods

A primary analysis was performed on 469 participants with quantifiable viral loads at baseline.

Results

Male and female participants had comparable nasal SARS-CoV-2 RNA levels at study entry and throughout follow-up. However, sex-specific differences in viral shedding emerged when stratified by symptom duration. In the first 3 days after symptom onset, female participants exhibited higher nasal SARS-CoV-2 RNA levels than males, but lower viral RNA levels thereafter. The higher viral RNA levels in females during the earliest phase of acute COVID-19 were observed even after adjusting for age, race, and region of enrollment. Female participants also tended to have higher symptom scores across days since symptom onset, but no significant correlation was observed between nasal SARS-CoV-2 RNA levels and symptom score regardless of sex.

Conclusion

These findings highlight the impact of sex on both viral shedding and symptom dynamics and underscore the importance of considering time since symptom onset when evaluating antiviral therapies for respiratory viruses in clinical trials.

Schlagwörter

Stichwörter der Autor:innen

Acute SARS-CoV-2 InfectionDays Since Symptom OnsetNasal Viral RNA SheddingSex DifferencesSymptom Dynamics

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Weill Cornell Medicine, New York, New York.
  • University of Washington, Seattle, Washington.
  • Fred Hutch Cancer Center, Seattle, Washington.
  • Stanford University School of Medicine, Stanford, California.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Kung, E., Deo, R., Choudhary, M. C., Chew, K. W., Evering, T. H., Ignacio, R. B., Jagannathan, P., Flynn, J. P., Regan, J., Moser, C., Giganti, M. J., Hughes, M. D., Ritz, J., Javan, A. C., Greninger, A. L., Singh, U., Fischer, W., Daar, E. S., Wohl, D. A., …, & ACTIV-2/A5401 Study Team (2026). Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19. Pathogens and Immunity, 11(1), 142-153. https://doi.org/10.20411/pai.v11i1.971

Vancouver

Kung E, Deo R, Choudhary MC, Chew KW, Evering TH, Ignacio RB, et al. Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19. Pathogens and Immunity. 2026;11(1):142-153. doi:10.20411/pai.v11i1.971

BibTeX
@article{Kung2026,
  author = {Kung, Evelyn and Deo, Rinki and Choudhary, Manish C and Chew, Kara W and Evering, Teresa H and Ignacio, Rachel Bender and Jagannathan, Prasanna and Flynn, James P and Regan, James and Moser, Carlee and Giganti, Mark J and Hughes, Michael D and Ritz, Justin and Javan, Arzhang Cyrus and Greninger, Alexander L and Singh, Upinder and Fischer, William and Daar, Eric S and Wohl, David A and Eron, Joseph J and Currier, Judith S and Coombs, Robert W and Smith, Davey M and Li, Jonathan Z and ACTIV-2/A5401 Study Team, ACTIV-2/A5401 Study Team},
  title = {Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19},
  journal = {Pathogens and Immunity},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {142--153},
  doi = {10.20411/pai.v11i1.971}
}
Kostenlos starten →